Back to Search Start Over

99m Tc-MIBI SPECT/CT Evaluation of a Renal Collision Tumor.

Authors :
Ali AA
Sivathapandi T
Gupta R
Master VA
Marcus C
Source :
Clinical nuclear medicine [Clin Nucl Med] 2023 Aug 01; Vol. 48 (8), pp. e390-e392. Date of Electronic Publication: 2023 Jun 17.
Publication Year :
2023

Abstract

Abstract: Preoperative differentiation of oncocytomas from renal cell carcinoma (RCC) is often challenging. 99m Tc-MIBI imaging could play a potential role in differentiating oncocytoma from RCC, which in turn could guide surgical decision-making. We present the use of 99m Tc-MIBI SPECT/CT to characterize a renal mass in a 66-year-old man with a complex medical history, including history of bilateral oncocytomas. 99m Tc-MIBI SPECT/CT showed features suspicious of a malignant tumor, which was confirmed postnephrectomy as a chromophobe and papillary RCC collision tumor. This case supports 99m Tc-MIBI imaging for preoperative differentiation of benign versus malignant renal tumors.<br />Competing Interests: Conflicts of interest and sources of funding: none declared.<br /> (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)

Details

Language :
English
ISSN :
1536-0229
Volume :
48
Issue :
8
Database :
MEDLINE
Journal :
Clinical nuclear medicine
Publication Type :
Academic Journal
Accession number :
37335313
Full Text :
https://doi.org/10.1097/RLU.0000000000004729